Did anyone notice a sector on ABC's Health Report (Norman Swan) on 15th May: Gene therapy advances for Duchenne muscular distropy - the FDA has voted that at their formal meeting at the end of May, approval moves forward for a gene herapy for Duchenne? How is this going to affect our ongoing research?
Did anyone notice a sector on ABC's Health Report (Norman Swan)...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.001(1.35%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 7.4¢ | 7.5¢ | 7.3¢ | $25.98K | 350.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15553 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 146315 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.001 ( 1.35 %) |
||||
| Open | High | Low | Volume | ||
| 7.3¢ | 7.5¢ | 7.3¢ | 48397 | ||
| Last updated 15.37pm 17/05/2024 ? | |||||
| PER (ASX) Chart |